PMID- 21637744 OWN - NLM STAT- MEDLINE DCOM- 20110929 LR - 20211109 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 6 IP - 5 DP - 2011 TI - HIV-1-infected and immune-activated macrophages induce astrocytic differentiation of human cortical neural progenitor cells via the STAT3 pathway. PG - e19439 LID - 10.1371/journal.pone.0019439 [doi] LID - e19439 AB - Diminished adult neurogenesis is considered a potential mechanism in the pathogenesis of HIV-1-associated dementia (HAD). In HAD, HIV-1-infected and immune-activated brain mononuclear phagocytes (MP; perivascular macrophages and microglia) drive central nervous system (CNS) inflammation and may alter normal neurogenesis. We previously demonstrated HIV-1-infected and lipopolysaccharide (LPS) activated monocyte-derived macrophages (MDM) inhibit human neural progenitor cell (NPC) neurogenesis, while enhancing astrogliogenesis through the secretion of the inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), in vitro and in vivo. Here we further test the hypothesis that HIV-1-infected/activated MDM promote NPC astrogliogenesis via activation of the transcription factor signal transducer and activator of transcription 3 (STAT3), a critical factor for astrogliogenesis. Our results show that LPS-activated MDM-conditioned medium (LPS-MCM) and HIV-infected/LPS-activated MDM-conditioned medium (LPS+HIV-MCM) induced Janus kinase 1 (Jak1) and STAT3 activation. Induction of the Jak-STAT3 activation correlated with increased glia fibrillary acidic protein (GFAP) expression, demonstrating an induction of astrogliogenesis. Moreover, STAT3-targeting siRNA (siSTAT3) decreased MCM-induced STAT3 activation and NPC astrogliogenesis. Furthermore, inflammatory cytokines (including IL-6, IL-1beta and TNF-alpha) produced by LPS-activated and/or HIV-1-infected MDM may contribute to MCM-induced STAT3 activation and astrocytic differentiation. These observations were confirmed in severe combined immunodeficient (SCID) mice with HIV-1 encephalitis (HIVE). In HIVE mice, siRNA control (without target sequence, sicon) pre-transfected NPCs injected with HIV-1-infected MDM showed more astrocytic differentiation and less neuronal differentiation of NPCs as compared to NPC injection alone. siSTAT3 abrogated HIV-1-infected MDM-induced astrogliogenesis of injected NPCs. Collectively, these observations demonstrate that HIV-1-infected/activated MDM induces NPC astrogliogenesis through the STAT3 pathway. This study generates important data elucidating the role of brain inflammation in neurogenesis and may provide insight into new therapeutic strategies for HAD. FAU - Peng, Hui AU - Peng H AD - Laboratory of Neuroimmunology and Regenerative Therapy, University of Nebraska Medical Center, Omaha, Nebraska, United States of America. hpeng@unmc.edu FAU - Sun, Lijun AU - Sun L FAU - Jia, Beibei AU - Jia B FAU - Lan, Xiqian AU - Lan X FAU - Zhu, Bing AU - Zhu B FAU - Wu, Yumei AU - Wu Y FAU - Zheng, Jialin AU - Zheng J LA - eng GR - P01 NS043985/NS/NINDS NIH HHS/United States GR - P01NS43985/NS/NINDS NIH HHS/United States GR - R21 NS066841/NS/NINDS NIH HHS/United States GR - R01 NS061642/NS/NINDS NIH HHS/United States GR - R01NS61642/NS/NINDS NIH HHS/United States GR - R01 NS041858/NS/NINDS NIH HHS/United States GR - P20RR15635/RR/NCRR NIH HHS/United States GR - P20 RR015635/RR/NCRR NIH HHS/United States GR - R01 NS41858/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20110527 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Lipopolysaccharides) RN - 0 (RNA, Small Interfering) RN - 0 (STAT3 Transcription Factor) RN - 0 (STAT3 protein, human) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 2.7.10.2 (Janus Kinases) SB - IM MH - Adult MH - Animals MH - Astrocytes/*cytology/drug effects MH - *Cell Differentiation/drug effects MH - Cerebral Cortex/cytology MH - Enzyme Activation/drug effects MH - HIV Infections/*immunology/virology MH - HIV-1/drug effects/immunology MH - Humans MH - Janus Kinases/metabolism MH - Lipopolysaccharides/pharmacology MH - Macrophage Activation/drug effects/*immunology MH - Macrophages/drug effects/enzymology/immunology/*virology MH - Mice MH - Monocytes/cytology/drug effects/metabolism MH - Neural Stem Cells/*cytology/drug effects/metabolism MH - Neurogenesis/drug effects MH - RNA, Small Interfering/metabolism MH - STAT3 Transcription Factor/genetics/*metabolism MH - Signal Transduction/drug effects MH - Tumor Necrosis Factor-alpha/pharmacology PMC - PMC3103496 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2011/06/04 06:00 MHDA- 2011/10/01 06:00 PMCR- 2011/05/27 CRDT- 2011/06/04 06:00 PHST- 2010/08/20 00:00 [received] PHST- 2011/04/06 00:00 [accepted] PHST- 2011/06/04 06:00 [entrez] PHST- 2011/06/04 06:00 [pubmed] PHST- 2011/10/01 06:00 [medline] PHST- 2011/05/27 00:00 [pmc-release] AID - PONE-D-10-00609 [pii] AID - 10.1371/journal.pone.0019439 [doi] PST - ppublish SO - PLoS One. 2011;6(5):e19439. doi: 10.1371/journal.pone.0019439. Epub 2011 May 27.